Nepidermin

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Logo pink
Stay in the know!
As part of our commitment to providing the most up-to-date drug information, we will be releasing #DrugBankUpdates with our newly added curated drug pages.
#DrugBankUpdates
Name
Nepidermin
Accession Number
DB14145
Type
Biotech
Groups
Experimental
Description
Not Available
Synonyms
  • Beta-urogastrone
  • Epidermal growth factor (human)
  • Epidermal growth factor biosynthetic human
  • Epidermal growth factor human
  • H-EGF
  • Human EGF
  • Human epidermal growth factor
  • Human urogastrone
  • Nepidermina
  • N├ępidermine
  • Nepiderminum
  • Recombinant human epidermal growth factor
  • rhEGF
  • Urogastrone
Over the Counter Products
NameDosageStrengthRouteLabellerMarketing StartMarketing End
EASYDEW DW EGF Derma Needle 3000 ShotSolution0.000045 mg/45mgTopicalDn Company Co.,Ltd.2018-03-01Not applicableUs
Easydew EX Repair Control Repair Control EgfLiquid0.0002 g/20mLTopicalDn Company Co.,Ltd.2018-02-01Not applicableUs
EASYDEW EX REPAIR CONTROL REPAIR CONTROL EGF 3mLLiquid0.03 mg/3mLTopicalDn Company Co.,Ltd.2018-07-01Not applicableUs
Additional Data Available
  • Application Number
    Application Number

    A unique ID assigned by the FDA when a product is submitted for approval by the labeller.

    Learn more
  • Product Code
    Product Code

    A governmentally-recognized ID which uniquely identifies the product within its regulatory market.

    Learn more
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing End
ARTEMES 3R Effect Hyaluronic AmpouleNepidermin (0.05 mg/5mL) + Adenosine (0.002 g/5mL) + Nicotinamide (0.10 g/5mL)LiquidTopicalDn Company Co.,Ltd.2019-03-01Not applicableUs
Artemes 3R effect hyaluronic maskNepidermin (0.33 mg/33g) + Adenosine (0.01 g/33g) + Nicotinamide (0.66 g/33g)PatchTopicalDn Company Co.,Ltd.2019-03-01Not applicableUs
Cosmeceutical Mask PackNepidermin (0.044 mg/22g) + Basic Fibroblast Growth Factor (0.044 mg/22g) + Mecasermin (0.044 mg/22g) + Palmitoyl oligopeptide (0.044 mg/22g) + Prezatide copper (0.22 mg/22g) + Thioredoxin (0.044 mg/22g)PatchTopicalYBK Investment, INC2013-10-212013-10-29Us
Cosmeceutical Mask PackNepidermin (0.044 mg/22g) + Basic Fibroblast Growth Factor (0.044 mg/22g) + Mecasermin (0.044 mg/22g) + Palmitoyl oligopeptide (0.044 mg/22g) + Prezatide copper (0.22 mg/22g) + Thioredoxin (0.044 mg/22g)PatchTopicalYBK Investment, INC2013-10-21Not applicableUs
Dermaheal Cosmeceutical Mask Pack PlusNepidermin (0.044 mg/22g) + Basic Fibroblast Growth Factor (0.044 mg/22g) + Mecasermin (0.044 mg/22g) + Palmitoyl oligopeptide (0.044 mg/22g) + Prezatide copper (0.22 mg/22g) + Thioredoxin (0.044 mg/22g)PatchTopicalYBK Investment, INC2013-10-21Not applicableUs
EASYDEW DW EGF Derma Oneshot AmpouleNepidermin (0.000001 mg/1.2mL) + Adenosine (0.00048 mg/1.2mL) + Nicotinamide (0.024 mg/1.2mL)LiquidTopicalDn Company Co.,Ltd.2018-03-01Not applicableUs
Easydew EX Repair Control Active Soothing SerumNepidermin (0.00012 g/40mL) + Adenosine (0.016 g/40mL) + Nicotinamide (0.8 g/40mL)CreamTopicalDn Company Co.,Ltd.2018-02-01Not applicableUs
Easydew EX Repair Control Renewal MoistureNepidermin (0.0001 g/50mL) + Adenosine (0.02 g/50mL) + Nicotinamide (1.0 g/50mL)CreamTopicalDn Company Co.,Ltd.2018-02-01Not applicableUs
Le-Blen EGF SerumNepidermin (0.54 g/56.7g) + Sodium hyaluronate (0.4 g/56.7g)LotionTopicalLeBlen Beauty Inc2018-04-24Not applicableUs
Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing End
ARTEMES 3R Effect Hyaluronic AmpouleNepidermin (0.05 mg/5mL) + Adenosine (0.002 g/5mL) + Nicotinamide (0.10 g/5mL)LiquidTopicalDn Company Co.,Ltd.2019-03-01Not applicableUs
Artemes 3R effect hyaluronic maskNepidermin (0.33 mg/33g) + Adenosine (0.01 g/33g) + Nicotinamide (0.66 g/33g)PatchTopicalDn Company Co.,Ltd.2019-03-01Not applicableUs
Cosmeceutical Mask PackNepidermin (0.044 mg/22g) + Basic Fibroblast Growth Factor (0.044 mg/22g) + Mecasermin (0.044 mg/22g) + Palmitoyl oligopeptide (0.044 mg/22g) + Prezatide copper (0.22 mg/22g) + Thioredoxin (0.044 mg/22g)PatchTopicalYBK Investment, INC2013-10-21Not applicableUs
Cosmeceutical Mask PackNepidermin (0.044 mg/22g) + Basic Fibroblast Growth Factor (0.044 mg/22g) + Mecasermin (0.044 mg/22g) + Palmitoyl oligopeptide (0.044 mg/22g) + Prezatide copper (0.22 mg/22g) + Thioredoxin (0.044 mg/22g)PatchTopicalYBK Investment, INC2013-10-212013-10-29Us
Dermaheal Cosmeceutical Mask Pack PlusNepidermin (0.044 mg/22g) + Basic Fibroblast Growth Factor (0.044 mg/22g) + Mecasermin (0.044 mg/22g) + Palmitoyl oligopeptide (0.044 mg/22g) + Prezatide copper (0.22 mg/22g) + Thioredoxin (0.044 mg/22g)PatchTopicalYBK Investment, INC2013-10-21Not applicableUs
EASYDEW DW EGF Derma Needle 3000 ShotNepidermin (0.000045 mg/45mg)SolutionTopicalDn Company Co.,Ltd.2018-03-01Not applicableUs
EASYDEW DW EGF Derma Oneshot AmpouleNepidermin (0.000001 mg/1.2mL) + Adenosine (0.00048 mg/1.2mL) + Nicotinamide (0.024 mg/1.2mL)LiquidTopicalDn Company Co.,Ltd.2018-03-01Not applicableUs
Easydew EX Repair Control Active Soothing SerumNepidermin (0.00012 g/40mL) + Adenosine (0.016 g/40mL) + Nicotinamide (0.8 g/40mL)CreamTopicalDn Company Co.,Ltd.2018-02-01Not applicableUs
Easydew EX Repair Control Renewal MoistureNepidermin (0.0001 g/50mL) + Adenosine (0.02 g/50mL) + Nicotinamide (1.0 g/50mL)CreamTopicalDn Company Co.,Ltd.2018-02-01Not applicableUs
Easydew EX Repair Control Repair Control EgfNepidermin (0.0002 g/20mL)LiquidTopicalDn Company Co.,Ltd.2018-02-01Not applicableUs
International/Other Brands
Easyef / Genesoft / Kang He Su / Regen-D
Categories
UNII
TZK30RF92W
CAS number
62253-63-8

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Additional Data Available
Adverse Effects

Comprehensive structured data on known drug adverse effects with statistical prevalence. MedDRA and ICD10 ids are provided for adverse effect conditions and symptoms.

Learn more
Additional Data Available
Contraindications

Structured data covering drug contraindications. Each contraindication describes a scenario in which the drug is not to be used. Includes restrictions on co-administration, contraindicated populations, and more.

Learn more
Additional Data Available
Blackbox Warnings

Structured data representing warnings from the black box section of drug labels. These warnings cover important and dangerous risks, contraindications, or adverse effects.

Learn more
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

References

General References
Not Available
External Links
Wikipedia
Nepidermin

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
1, 2RecruitingTreatmentAdvanced Head and Neck Squamous Cell Carcinoma / ALK Gene Mutation / EGFR Gene Mutations / Lung Non-Small Cell Carcinoma / Metastatic Lung Non-Small Cell Carcinoma / PD-L1 positive / Recurrent Head and Neck Squamous Cell Carcinoma / Recurrent Non-Small Cell Lung Carcinoma / Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 / Stage III Lung Cancer AJCC v8 / Stage IIIA Lung Cancer AJCC v8 / Stage IIIB Lung Cancer AJCC v8 / Stage IIIb Non-small Cell Lung Cancer / Stage IIIC Lung Cancer AJCC v8 / Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 / Stage IV Lung Cancer AJCC v8 / Stage IV Non-Small Cell Lung Cancer / Stage IVA Lung Cancer AJCC v8 / Stage IVB Lung Cancer AJCC v8 / Unresectable Lung Non-Small Cell Carcinoma1
2Active Not RecruitingTreatmentColorectal Cancers1
2CompletedPreventionOral Mucositis1
2RecruitingTreatmentHER2/Neu+ Uterine Serous Carcinoma1
3CompletedTreatmentDiabetic Foot Ulcer Patients With Uncontrolled Diabetes Mellitus1
3Not Yet RecruitingTreatmentDiabetic Foot Ulcers (DFU) / Epidermal Growth Factor1
3Unknown StatusTreatmentStomatitis1
Not AvailableRecruitingPreventionDrug-Related Side Effects and Adverse Reactions / Epidermal Growth Factor1
Not AvailableRecruitingTreatmentDrug-Related Side Effects and Adverse Reactions / Epidermal Growth Factor1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
FormRouteStrength
PatchTopical
SolutionTopical0.000045 mg/45mg
LiquidTopical
CreamTopical
LiquidTopical0.0002 g/20mL
LiquidTopical0.03 mg/3mL
LotionTopical
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Taxonomy

Classification
Not classified

Drug created on June 27, 2018 14:17 / Updated on December 02, 2019 10:10